sulotroban has been researched along with thromboxane b2 in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (43.48) | 18.7374 |
| 1990's | 13 (56.52) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giessler, C; Mentz, G; Mentz, P; Mest, HJ | 1 |
| Amerini, S; Ledda, F; Mantelli, L; Rubino, A | 1 |
| Giessler, C; Heinroth-Hoffmann, I; Mest, HJ | 1 |
| Bhakdi, S; Eberspächer, B; Grimminger, F; Holland, IB; Hugo, F; Obernitz, R; Seeger, W; Suttorn, N; Thomas, M; Walmrath, D | 1 |
| Brüne, B; Ullrich, V | 1 |
| Horton, AA; Wood, JM | 1 |
| Cattaneo, M; Lecchi, A; Mannucci, PM; Tenconi, PM | 1 |
| Asai, F; Ito, T; Kobayashi, S; Oshima, T | 1 |
| Battistini, B; Filep, JG; Sirois, P | 1 |
| Gerok, W; Häussinger, D; vom Dahl, S; Wettstein, M | 1 |
| Horohonich, S; Kopaciewicz, LJ; Kopia, GA; Ohlstein, EH; Shebuski, RJ; Storer, BL | 1 |
| Arnout, J; Bounameaux, H; Deckmyn, H; Gresele, P; Perez-Requejo, JL; Vermylen, J | 1 |
| Berk, L; van der Giessen, WJ; Verdouw, PD; Zijlstra, FJ | 1 |
| Hiller, E; Höfling, B; Riess, H; von Arnim, T | 1 |
| Decker, K; Gyufko, K; Reinke, M; Tran-Thi, TA | 1 |
| Bell, M; Eliasen, K; Hüttemeier, P; Mogensen, T; Qvist, J; Sørensen, JN | 1 |
| Patscheke, H | 1 |
| Bräuning, C; Hiller, E; Reinhardt, B; Riess, H | 1 |
| Müller-Beckmann, B; Patscheke, H; Pill, J; Schmidt, FH; Stegmeier, K; Witte, EC; Wolff, HP | 1 |
| Patscheke, H; Stegmeier, K | 1 |
| Flynn, JT; Linares, HA; Loick, HM; Rogers, S; Tokyay, R; Traber, DL; Traber, LD | 1 |
| Bäcker, A; Kramer, HJ; Meyer-Lehnert, H; Mohaupt, MG; Pinoli, F; Schlebusch, H | 1 |
| Becker, K; Bigl, H; Braquet, P; Förster, W; Lueddeckens, G; Sperling, J | 1 |
2 trial(s) available for sulotroban and thromboxane b2
| Article | Year |
|---|---|
Thromboxane A2 and prostacyclin do not modulate the systemic hemodynamic response to cold in humans.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; beta-Thromboglobulin; Blood Pressure; Cold Temperature; Double-Blind Method; Epoprostenol; Fingers; Humans; Imidazoles; Indomethacin; Male; Platelet Aggregation; Regional Blood Flow; Sulfonamides; Thromboxane A2; Thromboxane B2; Vascular Resistance; Vasoconstriction | 1985 |
Thromboxane receptor blockade versus cyclooxigenase inhibition: antiplatelet effects in patients.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angioplasty, Balloon; Arteriosclerosis; Aspirin; Bleeding Time; Blood Platelets; Clinical Trials as Topic; Collagen; Cyclooxygenase Inhibitors; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Receptors, Cell Surface; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxane B2; Thromboxanes | 1986 |
21 other study(ies) available for sulotroban and thromboxane b2
| Article | Year |
|---|---|
Interactions of prostanoids with the platelet activating factors.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Azepines; Guinea Pigs; Heart; Iloprost; In Vitro Techniques; Indomethacin; Myocardial Contraction; Perfusion; Platelet Activating Factor; Prostaglandins; Sulfonamides; Thromboxane A2; Thromboxane B2; Triazoles | 1992 |
Effects of thromboxane agonists on cardiac adrenergic neurotransmission.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Biphenyl Compounds; Dose-Response Relationship, Drug; Electric Stimulation; Guinea Pigs; Heart Atria; In Vitro Techniques; Male; Norepinephrine; Prostaglandin Endoperoxides, Synthetic; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Sympathetic Nervous System; Synaptic Transmission; Thromboxane A2; Thromboxane B2 | 1992 |
Relevance of vasoactive mediators for the blood pressure effects of intravenous arachidonic acid injection in rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acid; Aspirin; Blood Pressure; Cyproheptadine; Diterpenes; Ginkgolides; Imidazoles; Injections, Intravenous; Lactones; Male; Naphthalenes; Rats; Rats, Inbred Strains; Sulfonamides; Thromboxane B2 | 1992 |
Lung vascular injury after administration of viable hemolysin-forming Escherichia coli in isolated rabbit lungs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Blood Pressure; Capillary Permeability; Epoprostenol; Escherichia coli; Female; Hemolysin Proteins; Hypertension, Pulmonary; In Vitro Techniques; L-Lactate Dehydrogenase; Lung; Male; Neutrophils; Perfusion; Potassium; Pulmonary Artery; Rabbits; Receptors, Prostaglandin; Receptors, Thromboxane; Respiratory Insufficiency; Sulfonamides; Thromboxane B2; Thromboxanes | 1991 |
Different calcium pools in human platelets and their role in thromboxane A2 formation.
Topics: Antioxidants; Blood Platelets; Calcium; Calcium-Transporting ATPases; Fibrinolytic Agents; Humans; Hydroquinones; Nigericin; Platelet Activation; Prostaglandin-Endoperoxide Synthases; Sulfonamides; Terpenes; Thapsigargin; Thrombin; Thromboxane A2; Thromboxane B2 | 1991 |
Prevention of Ca(2+)-induced or thromboxane B2-induced hepatocyte plasma membrane bleb formation by thromboxane receptor antagonists.
Topics: Animals; Calcimycin; Calcium; Cell Death; Cell Membrane; Liver; Male; Phenylacetates; Rats; Receptors, Prostaglandin; Receptors, Thromboxane; Signal Transduction; SRS-A; Sulfonamides; Thromboxane B2 | 1991 |
In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Arachidonic Acid; Aspirin; Blood Platelets; Collagen; Drug Interactions; Female; Humans; Male; Malondialdehyde; Phthalic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Sulfonamides; Thromboxane B2 | 1991 |
Role of activated platelets in endotoxin-induced DIC in rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Coagulation; Disseminated Intravascular Coagulation; Endotoxins; Epoprostenol; Fibrin; Humans; Imidazoles; Kidney Glomerulus; Male; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Count; Prostaglandins, Synthetic; Rats; Rats, Inbred Strains; Sulfonamides; Thromboxane B2; Thromboxane-A Synthase; Ticlopidine | 1990 |
Endothelin induces thromboxane release and contraction of isolated guinea-pig airways.
Topics: Animals; Anti-Arrhythmia Agents; Bronchi; Dose-Response Relationship, Drug; Endothelins; Epoprostenol; Guinea Pigs; Lung; Male; Muscle Contraction; Muscle, Smooth; Phenylacetates; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxane A2; Thromboxane B2; Thromboxanes; Trachea | 1990 |
Stimulation of release of prostaglandin D2 and thromboxane B2 from perfused rat liver by extracellular adenosine.
Topics: Acetophenones; Adenosine; Animals; Blood Pressure; Glucose; Ibuprofen; Indomethacin; Liver; Male; Portal System; Prostaglandin D2; Rats; Rats, Inbred Strains; Secretory Rate; Sulfonamides; Thromboxane B2 | 1990 |
Combination of the thromboxane receptor antagonist, sulotroban (BM 13.177; SK&F 95587), with streptokinase: demonstration of thrombolytic synergy.
Topics: Animals; Dogs; Drug Synergism; Fibrinolytic Agents; Hemodynamics; Heparin; In Vitro Techniques; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Receptors, Prostaglandin; Receptors, Thromboxane; Regional Blood Flow; Streptokinase; Sulfonamides; Thromboxane A2; Thromboxane B2 | 1989 |
The effect of the thromboxane receptor antagonist BM 13.177 on experimentally induced coronary artery thrombosis in the pig.
Topics: Animals; Anti-Arrhythmia Agents; Aspirin; Coronary Disease; Coronary Thrombosis; Electric Stimulation; Hemodynamics; In Vitro Techniques; Platelet Aggregation; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Swine; Thromboxane B2 | 1988 |
Output and effects of thromboxane produced by the liver perfused with phorbol myristate acetate.
Topics: Animals; Bile; Female; Imidazoles; Kinetics; Liver; Perfusion; Prostaglandins; Pyridines; Rats; Rats, Inbred Strains; Reference Values; Sulfonamides; Tetradecanoylphorbol Acetate; Thromboxane B2; Thromboxane-A Synthase | 1988 |
Effects of a thromboxane antagonist (BM 13.177) during endotoxin-induced pulmonary vasoconstriction in sheep.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Endotoxins; Escherichia coli; Female; Hypertension, Pulmonary; Lung; Sheep; Sulfonamides; Thromboxane A2; Thromboxane B2; Vasoconstriction | 1986 |
Thromboxane synthase inhibition potentiates washed platelet activation by endogenous and exogenous arachidonic acid.
Topics: Arachidonic Acid; Arachidonic Acids; Blood Platelets; Collagen; Drug Interactions; Humans; Hydrogen Peroxide; Imidazoles; In Vitro Techniques; Indomethacin; Methylmercury Compounds; Oxidoreductases; Platelet Aggregation; Serotonin; Serum Albumin; Sulfonamides; Thromboxane B2; Thromboxane-A Synthase | 1985 |
Effects of BM 13.177, a new antiplatelet drug in patients with atherosclerotic disease.
Topics: Arteriosclerosis; beta-Thromboglobulin; Dose-Response Relationship, Drug; Fibrinolytic Agents; Humans; Male; Metabolic Clearance Rate; Middle Aged; Platelet Aggregation; Platelet Factor 4; Sulfonamides; Thromboxane B2 | 1984 |
The pharmacological profile of the thromboxane A2 antagonist BM 13.177. A new anti-platelet and anti-thrombotic drug.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Epoprostenol; Female; Fibrinolytic Agents; Guinea Pigs; Male; Muscle Contraction; Muscle, Smooth, Vascular; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Rabbits; Sulfonamides; Thrombosis; Thromboxane A2; Thromboxane B2; Thromboxanes | 1984 |
Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Collagen; Dose-Response Relationship, Drug; Epinephrine; Humans; Hydrogen Peroxide; Imidazoles; Indomethacin; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Prostaglandins E; Serotonin; Sulfonamides; Thromboxane A2; Thromboxane B2; Thromboxanes | 1984 |
Thromboxane receptor blockade with BM 13,177 following toxic airway damage by smoke inhalation in sheep.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Carboxyhemoglobin; Cardiac Output; Female; Hemodynamics; Leukocyte Count; Neutrophils; Organ Size; Oxygen; Pulmonary Circulation; Receptors, Thromboxane; Sheep; Smoke Inhalation Injury; Sulfonamides; Thromboxane B2; Vascular Resistance | 1993 |
Effects of thromboxane A2 receptor blockade on oliguric ischemic acute renal failure in conscious rats.
Topics: Acute Kidney Injury; Adenosine Triphosphate; Animals; Calcium; Female; Ischemia; Kidney; Mitochondria; Oliguria; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane; Sodium-Potassium-Exchanging ATPase; Sulfonamides; Thromboxane B2 | 1993 |
Importance of secondary TXA2 release in mediating of endothelin-1 induced bronchoconstriction and vasopressin in the guinea-pig.
Topics: Animals; Aspirin; Blood Pressure; Bronchoalveolar Lavage Fluid; Bronchoconstriction; Endothelins; Guinea Pigs; Imidazoles; Male; Naphthalenes; Prostaglandin-Endoperoxide Synthases; Receptors, Thromboxane; Sulfonamides; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Vasopressins | 1993 |